Search
for
Sort by
Research 541–570 of 735
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- NIGELLA SATIVA L.: AN OVERVIEW
- Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Study of Skin Expression of MicroRNA-146a in Patients with Alopacia Areata
- Severe cutaneous adverse reactions to drugs
- Global, Regional, and National Burden of Alopecia Areata in Children and Adolescents Aged 0-19 years from 1990 to 2021 and Projection to 2040
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Prediction of the Mechanism of Shaoyao Gancao Decoction in the Treatment of Alopecia Areata by Network Pharmacology and Its Preliminary Verification Study
- New Modalities in the Treatment of Refractory Alopecia Areata
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Combination Therapy with Cyclosporine and Psoralen Plus Ultraviolet A in the Patients with Severe Alopecia Areata: A Retrospective Study with a Self-Controlled Design
- Probiotics in Dermatology: An Evidence-based Approach
- Transient stimulation of TRPV4‐expressing keratinocytes promotes hair follicle regeneration in mice
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Intestinal Lymphatic Biology, Drug Delivery, and Therapeutics: Current Status and Future Directions
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- Immune therapies for alopecia areata: evidence and new perspectives
- Overexpression of hypoxia-inducible factor-1α in hidradenitis suppurativa: the link between deviated immunity and metabolism
- Mechanisms of impairment in hair and scalp induced by hair dyeing and perming and potential interventions
- Research Progress on Construction Technology of 3D Human Skin Models and Its Application Prospects in Dermatology
- Genetic Insights into Acne, Androgenetic Alopecia, and Alopecia Areata: Implications for Mechanisms and Precision Dermatology
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- N6-methyladenosine RNA Methylation Correlates with Immune Microenvironment and Immunotherapy Response of Melanoma
- The Potential Relevance of the Microbiome to Hair Physiology and Regeneration: The Emerging Role of Metagenomics
- Skin Microbiome, Metabolome and Skin Phenome, from the Perspectives of Skin as an Ecosystem
- Efficacy of Local and Whole‐Body Phototherapy for the Treatment of Various Types of Alopecia Areata